The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children

University of California, San Diego120 enrolled

Overview

This study employs a cross-sectional design to profile the gut microbiome and urine metabolome in overweight/obese children with type 1 diabetes (T1D).

The investigators will obtain stool and urine samples from subjects aged 7-17 years in 4 groups: * Group 1: Obese or overweight children within 3 years of diagnosis of T1D * Group 2: Normal weight children within 3 years of diagnosis of T1D * Group 3: Obese or overweight children without T1D * Group 4: Normal weight children without T1D Type 1 diabetes will be defined according to American Diabetes Association criteria along with the presence of pancreatic autoantibodies (GAD65, ICA512, or insulin autoantibodies). Obese and overweight status will be defined by BMI \>85th percentile for age and gender according to CDC criteria. All subjects will provide one-time stool and first morning urine sample. Overweight or obese subjects will additionally have a point of care blood glucose and hemoglobin A1c measurement to ensure that they do not have diabetes. The investigators will perform 16S rRNA sequencing of stool bacteria and mass spectrometry measurement of urine metabolites.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Obesity Overweight Type 1 Diabetes Mellitus

Interventions

No interventionOTHER

No intervention

Eligibility

Sex: ALLMin age: 7 YearsMax age: 17 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age 7 to 17 years * Diagnosis of diabetes will be defined by current American Diabetes Association criteria ° (fasting glucose \> 126 mg/dl, 2 hour OGTT glucose \> 200 mg/dl; random glucose \> 200 with symptoms of hyperglycemia; or HbA1c \> 6.5%) * Diabetes duration \< 3 years * Presence of pancreatic autoimmunity (GAD65, ICA512, or insulin autoantibody positivity) * Adult caregiver willing to actively support study participation * Signed parental informed consent form and minor child informed assent form Exclusion Criteria: * Other significant organ system illness or condition (including psychiatric or developmental disorder) that, in the opinion of the investigator, would prevent participation

Locations (1)

Rady Children's Hospital Endocrinology Department

San Diego, California, United States

Outcomes

Primary Outcomes

Analysis of gut microbial composition and diversity by 16S rRNA sequencing

Time frame: 2 years

Secondary Outcomes

Analysis of urine metabolite concentrations measured by mass spectrometry

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.